CTRI Number |
CTRI/2023/12/060681 [Registered on: 22/12/2023] Trial Registered Prospectively |
Last Modified On: |
19/12/2023 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug Surgical/Anesthesia |
Study Design |
Randomized, Parallel Group, Placebo Controlled Trial |
Public Title of Study
|
A clinical trial to study the effect of two regimen, opioid and opioid free anaesthesia regimen in patients undergoing laparoscopic surgeries. |
Scientific Title of Study
|
A Randomized controlled trial to compare the postoperative analgesia and haemodynamic response between Opioid Free Anaesthesia regimen(OFA) and standard opioid anaesthesia technique among patients undergoing laparoscopic non cardiac surgeries. |
Trial Acronym |
NIL |
Secondary IDs if Any
|
Secondary ID |
Identifier |
nil |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
DrBlesita T Jose |
Designation |
post graduate student |
Affiliation |
Department of Anaesthesiology, Believers church medical college hospital thiruvalla |
Address |
Thrikkukaran house
varakkara
varandarappilly p o 1 BHK, Room No: GF00A
Believers church medical college hospital
Thiruvalla
Pathanamthitta
kerala Pathanamthitta KERALA 680303 India |
Phone |
8943186007 |
Fax |
|
Email |
blesitatjose@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
DR ASHU SARA MATHAI |
Designation |
HOD, DEPARTMENT OF ANAESTHESIA |
Affiliation |
HOD, DEPARTMENT OF ANAESTHESIOLOGY |
Address |
HOD
DEPARTMENT OF ANAESTHESIOLOGY
BELIEVERS CHURCH MEDICAL COLLEGE HOSPITAL
THIRUVALLA HOD
DEPARTMENT OF ANAESTHESIOLOGY
BELIEVERS CHURCH MEDICAL COLLEGE HOSPITAL
THIRUVALLA Pathanamthitta KERALA 689103 India |
Phone |
9888500240 |
Fax |
|
Email |
hod.anaesthesiology@bcmch.edu.in |
|
Details of Contact Person Public Query
|
Name |
DrBlesita T Jose |
Designation |
post graduate student |
Affiliation |
Department of Anaesthesiology, Believers church medical college hospital thiruvalla |
Address |
Thrikkukaran house
varakkara
varandarappilly p o 1 BHK, Room No: GF00A
Believers church medical college hospital
Thiruvalla
Pathanamthitta
kerala Pathanamthitta KERALA 680303 India |
Phone |
8943186007 |
Fax |
|
Email |
blesitatjose@gmail.com |
|
Source of Monetary or Material Support
|
Believers church medical college hospital THiruvalla |
|
Primary Sponsor
|
Name |
DrAshu Sara Mathai |
Address |
HOD
Department of anaesthesiology
Believers Church Medical College Hospital
Thiruvalla |
Type of Sponsor |
Other [Guide] |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
DR Blesita T jose |
Believers church medical college hospital Thiruvalla |
Operation Theatre complex
Department of Anaestheia
Believers church medical college hospital Thiruvalla Pathanamthitta KERALA |
8943186007
blesitatjose@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
INSTITUTIONAL ETHICS COMMITTEE BELIEVERS CHURCH MEDICAL COLLEGE HOSPITAL THIRUVALLA |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: O||Medical and Surgical, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Intervention |
DEXMEDETOMIDINE + KETAMINE + LIGNOCAINE SOLUTION |
a premixed solution of 50 mcg dexmedetomidine, 50 mg ketamine and 500
mg intravenous lignocaine with 0.9% normal saline to constitute a volume of 50 cc will be prepared.
10 ml of this solution will be drawn in a separate syringe for the bolus dose. The remaining 40 cc
solution will be used for maintenance dosing.Bolus dose will be given before induction and maintanance dose will be given throughout the surgery @ 1ml/10kg
|
Comparator Agent |
OPIOID (FENTANYL) |
a 10 cc syringe containing 10 ml of 2 mcg/kg fentanyl injection as bolus dose
and a 50 cc syringe with 40 ml of 0.9% normal saline solution will be prepared for maintenance
dosing. A top up dose of 25mcg of fentanyl will be given each hour if the surgery prolongs more
than 2 hours |
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
70.00 Year(s) |
Gender |
Both |
Details |
American society of anaesthesiologist (ASA) classification I,II,III
Patients undergoing elective, laparoscopic, non cardiac surgeries of less than 4 hours
duration |
|
ExclusionCriteria |
Details |
Patients who refuse consent/lack the capacity to give consent
Patient with known allergy to the study drugs used
Patient with co-existing liver or renal disease
Patients undergoing conversion to open surgical technique
Patients with preoperative uncontrolled hypertension (Preoperative BP>190/110 mmhg) or
hypotension (MAP<65 mmhg)
Pregnancy
Patients with Seizure disorder
Patients with psychiatric illnesses or on antipsychotic medications
Patients with Cardiac arrhythmias /AV block/ Bradycardia (<50/min) |
|
Method of Generating Random Sequence
|
Computer generated randomization |
Method of Concealment
|
Centralized |
Blinding/Masking
|
Not Applicable |
Primary Outcome
|
Outcome |
TimePoints |
Intraoperative haemodynamic stability (heart rate,blood pressure)
post operative analgesia using Numerical Rating Score |
Intraoperative haemodynamic stability (heart rate,blood pressure)
at 0,3,6,12,24 hours |
|
Secondary Outcome
|
Outcome |
TimePoints |
Ramsay sedation score |
24hours |
gastrointestinal recovery after surgery,haemodynamic instability,postoperative nausea and vomiting, respiratory depression,pruritus |
24hours |
quality of Recovery-15 |
24 hours |
|
Target Sample Size
|
Total Sample Size="120" Sample Size from India="120"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
Phase 2/ Phase 3 |
Date of First Enrollment (India)
|
01/01/2024 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
N/A |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - All of the individual participant data collected during the trial, after de-identiļ¬cation.
- What additional supporting information will be shared?
Response - Study Protocol Response - Informed Consent Form
- Who will be able to view these files?
Response - Anyone
- For what types of analyses will this data be available?
Response - Any purpose.
- By what mechanism will data be made available?
Response - Proposals should be directed to [blesitatjose@gmail.com].
- For how long will this data be available start date provided 01-01-2024 and end date provided 01-01-2029?
Response - Beginning 3 months and ending 5 years following article publication.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - nil
|
Brief Summary
|
This study is Randomized controlled single centre trial to compare the intraoperative haemodynamic stability, Postoperative analgesia and post operative adverse effects in terms of nausea and vomiting, sedation, respiratory depression, pruritis, ileus, heamodynamic instability of an opioid free anaesthesia regimen versus standard opioid based anaesthesia regimen in patients undergoing non cardiac laparoscopic surgeries. |